Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Jiafu Ji, Lin Chen et al.|The Lancet Oncology|2021Cited by 436
Downregulation of Notch1 inhibits the invasion and metastasis of human gastric cancer cells SGC7901 and MKN74 in vitro through PTEN activation and dephosphorylation of Akt and FAKXue‐Song Zhang, Yingwei Xue|Molecular Medicine Reports|2017Cited by 22
CD66b<sup>+</sup> neutrophils and α‐SMA<sup>+</sup> fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinomaXiliang Cong, Yingwei Xue|Cancer Medicine|2020Cited by 21
Efficacy of Lymph Node Location-Number Hybrid Staging System on the Prognosis of Gastric Cancer PatientsJunpeng Wu, Yingwei Xue|Cancers|2023Cited by 4